journal article·2026-06-10Open access

RNF138‐Mediated Ubiquitination and Degradation of NS5 Restricts Tick‐Borne Encephalitis Virus Infection

Jialiang Sun, Weijing Yang, Hao Zhou, Shuai Li, Xin Jiang, Jianyang Gu, Wenyan Zhang

Abstract

ABSTRACT Tick‐borne encephalitis virus (TBEV) causes severe neurological disease. However, whether host restricts its replication and the underlying mechanisms remain incompletely delineated. Here, we identify the E3 ubiquitin ligase RNF138 as an intrinsic restriction factor targeting the viral RNA‐dependent RNA polymerase (RdRp) NS5. Mechanistically, RNF138 directly interacts with the RdRp domain of NS5 through its ubiquitin‐interacting motif, catalyzes K48‐linked polyubiquitination and induces degradation of TBEV NS5. Ubiquitin‐remnant profiling and mutational analyses identify K372, K462, and K470 within NS5 as the ubiquitination sites, and mutating these residues leads to NS5 resistant to RNF138‐induced degradation. Functionally, RNF138 suppresses the replication of TBEV as well as Zika virus, a representative mosquito‐borne flavivirus, through recognizing and degrading NS5 proteins. Ectopic RNF138 reduces viral RNA levels in the brain and peripheral tissues of TBEV‐infected mice, mitigates neuroinflammatory responses, and improves survival. Notably, the antiviral activity is conserved among several mammalian RNF138 orthologs but absent in the arthropod homologs, highlighting a host‐specific antiviral adaptation. Together, these findings reveal RNF138‐mediated ubiquitination and degradation of NS5 as a mechanism of intrinsic defense against TBEV and provide a framework for exploring targeted destabilization of conserved flaviviral replicases.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Mosquito-borne diseases and control · Invertebrate Immune Response Mechanisms · Ubiquitin and proteasome pathways

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute of Virology and AIDS Research Centre of Infectious Diseases and Pathogen Biology Key Laboratory of Organ Regeneration and Transplantation of the Ministry of Education State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases the First Hospital of Jilin University Changchun China

Changchun Institute of Biological Products Co., Ltd Changchun China

Jilin Provincial Key Laboratory of Radiation Oncology & Therapy Department of Radiation Oncology & Therapy The First Hospital of Jilin University Changchun China

Funding

National Natural Science Foundation of China

References (57)

Show source-provided references
1. 10.1080/21505594.2021.199605910.1080/21505594.2021.1996059 ↗
2. 10.1002/advs.20240802410.1002/advs.202408024 ↗
3. 10.1080/22221751.2023.227889810.1080/22221751.2023.2278898 ↗
4. 10.1038/s41467‐024‐54010‐w10.1038/s41467‐024‐54010‐w ↗
5. 10.1002/rmv.247010.1002/rmv.2470 ↗
6. 10.1038/s41579‐026‐01277‐z10.1038/s41579‐026‐01277‐z ↗
7. 10.1021/acs.jmedchem.5c0070910.1021/acs.jmedchem.5c00709 ↗
8. 10.1073/pnas.240323512110.1073/pnas.2403235121 ↗
9. 10.15252/embr.20235742410.15252/embr.202357424 ↗
10. 10.1038/s41467‐024‐49758‐010.1038/s41467‐024‐49758‐0 ↗
11. 10.1038/s42003‐024‐05768‐810.1038/s42003‐024‐05768‐8 ↗
12. 10.1128/jvi.00297‐2410.1128/jvi.00297‐24 ↗
13. 10.1128/jvi.00868‐2510.1128/jvi.00868‐25 ↗
14. 10.1371/journal.ppat.101262610.1371/journal.ppat.1012626 ↗
15. 10.1038/s41586‐020‐2457‐810.1038/s41586‐020‐2457‐8 ↗
16. 10.1038/s41392‐023‐01335‐510.1038/s41392‐023‐01335‐5 ↗
17. 10.1128/jvi.00030‐2510.1128/jvi.00030‐25 ↗
18. 10.1186/s13578‐022‐00872‐w10.1186/s13578‐022‐00872‐w ↗
19. 10.1080/15548627.2022.212661410.1080/15548627.2022.2126614 ↗
20. 10.1016/j.chom.2011.08.00410.1016/j.chom.2011.08.004 ↗
21. 10.1371/journal.ppat.101162010.1371/journal.ppat.1011620 ↗
22. 10.1042/bj2007099510.1042/bj20070995 ↗
23. 10.1038/s41392‐022‐00985‐110.1038/s41392‐022‐00985‐1 ↗
24. 10.1038/ncb325910.1038/ncb3259 ↗
25. 10.7150/thno.11092510.7150/thno.110925 ↗
26. 10.1016/j.celrep.2023.11209710.1016/j.celrep.2023.112097 ↗
27. 10.1080/22221751.2024.240427110.1080/22221751.2024.2404271 ↗
28. 10.1016/j.ijbiomac.2025.14132810.1016/j.ijbiomac.2025.141328 ↗
29. 10.1038/nbt.420110.1038/nbt.4201 ↗
30. 10.1073/pnas.252577112210.1073/pnas.2525771122 ↗
31. 10.1038/s41586‐025‐09500‐210.1038/s41586‐025‐09500‐2 ↗
32. 10.1038/s41467‐024‐54628‐w10.1038/s41467‐024‐54628‐w ↗
33. 10.1073/pnas.250206412210.1073/pnas.2502064122 ↗
34. 10.1128/mbio.00208‐2510.1128/mbio.00208‐25 ↗
35. 10.1080/22221751.2025.254224610.1080/22221751.2025.2542246 ↗
36. 10.3390/pharmaceutics1504111110.3390/pharmaceutics15041111 ↗
37. 10.1016/j.bbrc.2005.11.17310.1016/j.bbrc.2005.11.173 ↗
38. 10.1016/j.bbi.2026.10656010.1016/j.bbi.2026.106560 ↗
39. 10.1016/j.phymed.2026.15787410.1016/j.phymed.2026.157874 ↗
40. 10.1038/s41467‐024‐49161‐910.1038/s41467‐024‐49161‐9 ↗
41. 10.1016/j.coviro.2025.10148710.1016/j.coviro.2025.101487 ↗
42. 10.1021/acs.jmedchem.5c0136410.1021/acs.jmedchem.5c01364 ↗
43. 10.1073/pnas.231797812110.1073/pnas.2317978121 ↗
44. 10.1128/jvi.00151‐1910.1128/jvi.00151‐19 ↗
45. 10.1038/s41467‐025‐56859‐x10.1038/s41467‐025‐56859‐x ↗
46. 10.1016/j.ejmech.2023.11541610.1016/j.ejmech.2023.115416 ↗
47. 10.1128/mbio.03097‐2210.1128/mbio.03097‐22 ↗
48. 10.1371/journal.ppat.101397010.1371/journal.ppat.1013970 ↗
49. 10.1128/jvi.01130‐2110.1128/jvi.01130‐21 ↗
50. 10.1371/journal.ppat.101303510.1371/journal.ppat.1013035 ↗
51. 10.1038/s41423‐025‐01334‐210.1038/s41423‐025‐01334‐2 ↗
52. 10.1038/s41392‐022‐01152‐210.1038/s41392‐022‐01152‐2 ↗
53. 10.1016/j.pt.2015.09.00910.1016/j.pt.2015.09.009 ↗
54. 10.1002/advs.20240582910.1002/advs.202405829 ↗
55. 10.1002/advs.20250079810.1002/advs.202500798 ↗
56. 10.1080/22221751.2024.231790910.1080/22221751.2024.2317909 ↗
57. 10.1186/s12974‐024‐03266‐610.1186/s12974‐024‐03266‐6 ↗